Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A group of neoplasms which arise from the ependymal lining of the cerebral ventricles and from the remnants of the central canal of the spinal cord. Ependymal tumors occur predominantly in children and young adults with varied morphological features and biological behavior. There are 4 types: ependymoma, anaplastic ependymoma, myxopapillary ependymoma and subependymoma. (WHO)
Biomarker and diagnostic research for ependymal tumor has been reported in the published literature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, gene therapy, and procedural interventions. Pipeline includes 2 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
25 publications have been identified in PubMed for ependymal tumor. Research spans Review / Meta-Analysis (24%), Diagnostic / Biomarker (20%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:27 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Testing and diagnosis research | 5 | 20% |
Laboratory research | 5 | 20% |
Clinical study results | 3 | 12% |
Disease patterns and progression | 3 | 12% |
Patient case studies | 2 | 8% |
Other research | 1 | 4% |
Satgunaseelan L (2026). [PMID: 42264943](https://pubmed.ncbi.nlm.nih.gov/42264943/). *Brain Pathol*. [Diagnostic / Biomarker]
Schnorrenberg J (2026). [PMID: 41834733](https://pubmed.ncbi.nlm.nih.gov/41834733/). *Neuropathology and applied neurobiology*. [Diagnostic / Biomarker]
Ghasemi DR (2026). [PMID: 41619789](https://pubmed.ncbi.nlm.nih.gov/41619789/). *Neuro-oncology*. [Review / Meta-Analysis]
Wesseling P (2026). [PMID: 40887057](https://pubmed.ncbi.nlm.nih.gov/40887057/). *Brain pathology (Zurich, Switzerland)*. [Review / Meta-Analysis]
Thomas AG (2026). [PMID: 41274771](https://pubmed.ncbi.nlm.nih.gov/41274771/). *Neuroimaging clinics of North America*. [Review / Meta-Analysis]
Zheng L (2026). [PMID: 41639901](https://pubmed.ncbi.nlm.nih.gov/41639901/). *Acta neuropathologica communications*. [Basic Science / Preclinical]
Hack K (2026). [PMID: 41273179](https://pubmed.ncbi.nlm.nih.gov/41273179/). *Neuro-oncology*. [Basic Science / Preclinical]
Vasiljevic A (2026). [PMID: 42115456](https://pubmed.ncbi.nlm.nih.gov/42115456/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Purkait S (2025). [PMID: 40137996](https://pubmed.ncbi.nlm.nih.gov/40137996/). *Acta neuropathologica*. [Diagnostic / Biomarker]
Jayawardena D (2025). [PMID: 40469371](https://pubmed.ncbi.nlm.nih.gov/40469371/). *Surgical neurology international*. [Epidemiology / Natural History]